$TWST News

Twist Bioscience: An AI And Rate Cut Play Dressed In A Lab Coat

Evercore ISI Group Downgrades Twist Bioscience to In-Line, Raises Price Target to $102

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107

Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $95

Investor’s Favored Twist Bioscience’s (TWST) Association with Technology Companies

Twist Bioscience Files Prospectus For Offering Mixed Shelf; Terms Undisclosed

Twist Bioscience: Huge Downside, With Little Hope Of Profits

Twist Bioscience (TWST) Stock Could Be 25.5% Overvalued After Its Recent Rally

TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $89

Canaccord Genuity Initiates Coverage On Twist Bioscience with Buy Rating, Announces Price Target of $90

Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.

Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?

Piper Sandler Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $85

Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?

Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million

Twist Bioscience Corporation (TWST) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow

How The Investment Story For Twist Bioscience (TWST) Is Evolving With Recent Developments

Is Twist Bioscience Corporation (TWST) a Strong Buy After Guggenheim Lifts Price Target?

Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference

Twist Bioscience Corporation (TWST) Analyst/Investor Day Transcript